Novo Nordisk A/S
Stocks making the biggest moves premarket: Apple, AMD, Uber, Alphabet, PDD and more
Check out the companies making headlines before the stock market open. Alphabet — The Google parent tumbled 7% after fourth-quarter revenue of $96.47 billion lagged the $96.56 billion estimated by analysts polled by LSEG. Alphabet also said it plans to invest $75 billion in 2025 as it expands its artificial-intelligence strategy, more than the $58.84 […]
Read More
Novo Nordisk shares rise on fourth-quarter profit beat, Wegovy sales jump
Medical bottles and syringe are seen with Novo Nordisk logo displayed on a screen in the background. Nurphoto | Nurphoto | Getty Images Shares of Novo Nordisk rose on Wednesday after the company reported better-than-expected net profit in the fourth quarter amid soaring demand for its Wegovy obesity drugs, but forecast a slight slowdown in […]
Read More
European markets open mixed ahead of more earnings reports; GSK up 6%
TotalEnergies posts 21% drop in annual profit French oil major TotalEnergies on Wednesday reported a sharp drop in full-year earnings, against a backdrop of lower crude prices and weak fuel demand. The oil and gas giant posted full-year 2024 adjusted net income of $18.3 billion, reflecting a 21% fall from $23.2 billion a year earlier. Analysts had expected TotalEnergies’ […]
Read More
Healthy Returns: Why people quit weight loss, diabetes drugs within one year
Packages of weight loss drugs Wegovy, Ozempic and Mounjaro. Picture Alliance | Getty Images A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. Happy Tuesday! Most people quit a highly popular class of weight loss and […]
Read More
FDA approves Novo Nordisk’s Ozempic to treat chronic kidney disease in those with diabetes, expanding its use
The Food and Drug Administration on Tuesday approved Novo Nordisk‘s Ozempic to treat chronic kidney disease in patients who also have Type 2 diabetes, expanding the use of the wildly popular injection in the U.S. The drug is already widely used and covered to treat Type 2 diabetes. The FDA’s decision means Ozempic can now […]
Read More
World’s largest luxury group LVMH posts better than feared full-year sales
A Louis Vuitton storefront in San Diego, California. Kevin Carter | Getty Images News | Getty Images The world’s largest luxury company LVMH on Tuesday reported better-than-expected full-year sales, in the strongest sign yet of a potential turnaround in the high-end sector. The owner of brands including Louis Vuitton, Moët & Chandon and Hennessy posted […]
Read More
Food-as-medicine startups hope Kennedy, if confirmed as HHS secretary, will boost their businesses
Robert Kennedy Jr., U.S. President-elect Donald Trump’s nominee to run the Department of Health and Human Services, arrives at the Hart Senate Office Building on Capitol Hill in Washington, U.S., December 16, 2024. Benoit Tessier | Reuters As Robert F. Kennedy Jr. faces two days of Senate confirmation hearings this week in his quest to […]
Read More
Stocks making the biggest moves midday: Texas Instruments, Grindr, Twilio and more
Check out the companies making headlines in midday trading. Verizon Communications — The telecom giant saw shares climbing 1.3% after the firm posted its strongest quarterly wireless subscriber growth in five years, boosted by solid demand for its customizable offerings like myPlan. Verizon reported earnings of $1.1 per share last quarter, matching an average estimate […]
Read More
Stocks making the biggest moves premarket: Twilio, Boeing, Novo Nordisk, CSX and more
Check out the companies making headlines before the stock market opens. Boeing — The airplane maker slipped slipped 1.3% after preliminary fourth-quarter financial results reflected ongoing struggles. Boeing said it expects to report a loss of $5.46 per share for the fourth quarter on revenue of $15.2 billion, less than analysts’ expectations, according to LSEG […]
Read More
Novo Nordisk shares pop 10% on early-stage weight loss drug trial results
A view of the logo of Novo Nordisk at the company’s office in Bagsvaerd, on the outskirts of Copenhagen, Denmark, March 8, 2024. Tom Little | Reuters Shares of Novo Nordisk jumped Friday after the Danish pharmaceutical giant reported positive early-stage results for its once weekly amycretin obesity drug. The trial showed average weight reduction […]
Read More